We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$44.9M
AUM Growth
+$15.2M
Cap. Flow
+$10.3M
Cap. Flow %
23.01%
Top 10 Hldgs %
66.25%
Holding
28
New
11
Increased
3
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.55M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.38M
3
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$2.17M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$2.11M
5
ALKS icon
Alkermes
ALKS
+$2.05M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.75M
2
MCK icon
McKesson
MCK
+$1.74M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.65M
4
TYME
Tyme Technologies, Inc. Common Stock
TYME
+$1.4M
5
CAH icon
Cardinal Health
CAH
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 84.3%
2 Miscellaneous 12.75%
3 Consumer Staples 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$104B
– –
-10,000
Closed -$1.74M
MRNA icon
27
PUT
Moderna
MRNA
$57B
– –
-10,000
Closed -$1.04M
NVAX icon
28
PUT
Novavax
NVAX
$1.49B
– –
-5,000
Closed -$558K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Healthcare Value Capital held 28 positions worth $44.9M, up 51% from $29.7M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Healthcare Value Capital deployed $10.3M of net new capital in Q1 2021, opening 11 new positions and adding to 3 existing holdings. Its largest new stake was Pfizer: 100,000 shares worth $3.62M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Tyme Technologies, Inc. Common Stock, an estimated $1.4M trimmed.

  • Healthcare Value Capital's largest Q1 2021 buy was Pfizer: 100,000 shares worth $3.62M.
  • Healthcare Value Capital added most to Gilead Sciences in Q1 2021, an estimated $1.61M increase.
  • Healthcare Value Capital's biggest Q1 2021 reduction was Tyme Technologies, Inc. Common Stock, cutting an estimated $1.4M.
  • Healthcare Value Capital fully exited AbbVie in Q1 2021, selling an estimated $3.75M.
  • Healthcare Value Capital's ten largest holdings make up 66% of its $44.9M portfolio in Q1 2021.
  • Healthcare Value Capital opened 11 new positions and closed 6 in Q1 2021.
  • Healthcare Value Capital's portfolio value rose 51% quarter-over-quarter to $44.9M.

Based on Healthcare Value Capital's 13F filing for Q1 2021, filed 17 May 2021.